Monopoly - Publications - Faculty & Research - Harvard Business School

Filter Results: (83)

Filter Results: (83)

Show Results For

Page 1 of 83 Results →

Are you looking for?

→Search All HBS Web

December 2024
Article

Coordinating the Energy Transition: Electrifying Transportation in California and Germany

By: Nicholas Goedeking and Jonas Meckling

California and Germany share ambitious emission reduction targets. Yet California is ahead of Germany in electrifying transportation by several metrics, including the number of public charging stations. We show that variation in the politics of coordination in... View Details

Keywords: Electric Vehicles; Coordination; Technology Adoption; Infrastructure; Transportation; Government and Politics; Energy; Utilities Industry; Germany; California

July 2024
Case

ZEISS: Commercializing Science

By: Maria P. Roche, Carlota Moniz and Daniela Beyersdorfer

Karl Lamprecht, President and CEO of the ZEISS AG Group, mused on how far ZEISS had come in 175 years of being a pioneer in optics, and how the course he had charted since taking the helm of the company could keep it on track. In his role, he oversaw the four core... View Details

February 2024 (Revised May 2024)
Case

Lina Khan at the FTC: Redefining Antitrust in the Age of Big Tech

By: Joseph L. Badaracco Jr. and Susan Pinckney

In 2023 and 2024, the Federal Trade Commission and U.S. Department of Justice sued Google, Amazon, and Apple claiming antitrust violations. These lawsuits marked a shift in U.S. antitrust enforcement away from the Chicago School and towards the New Brandeis school of... View Details

Keywords: Transition; Government Administration; Lawsuits and Litigation; Monopoly; Technology Industry; United States; European Union; China; India

January 11, 2024
Article

Understanding the Tradeoffs of the Amazon Antitrust Case

By: Chiara Farronato, Andrey Fradkin, Andrei Hagiu and Dionne Lomax

Regulators in the United States and Europe have been taking on Big Tech, challenging what they say are the companies’ anti-competitive and predatory strategies that harm consumers and third-party users of their platforms. This article examines the FTC’s case against... View Details

Keywords: Monopoly; Governing Rules, Regulations, and Reforms; Market Design; Lawsuits and Litigation

Summer 2023
Article

(Un)principled Agents: Monitoring Loyalty after the End of the Royal African Company Monopoly

By: Anne Ruderman and Marlous van Waijenburg

The revocation of the Royal African Company's monopoly in 1698 inaugurated a transformation of the transatlantic slave trade. While the RAC’s exit from the slave trade has received scholarly attention, little is known about the company’s response to the loss of its... View Details

Keywords: Slavery; Organizational Change and Adaptation; Business History; Monopoly; History; Business and Government Relations

Find at Harvard

2023
Book

Precarious Ties: Business and the State in Authoritarian Asia

By: Meg Rithmire

Developing Asia has been the site of some of the last century's fastest growing economies as well as some of the world's most durable authoritarian regimes. Many accounts of rapid growth alongside monopolies on political power have focused on crony relationships... View Details

Keywords: Business and Government Relations; Developing Countries and Economies; Economic Systems; Crime and Corruption; China; Indonesia; Malaysia

Find at Harvard

Register to Read

March 2022 (Revised April 2022)
Teaching Note

France Télécom (A), (B), and (C)

By: Ashley Whillans

This case series discusses the evolution of France Télécom (now Orange) from a national telephone monopoly to a private company. During this process, the company faced numerous challenges including the entry of new competition from other countries and a workforce that... View Details

Keywords: Competition; Compensation and Benefits; Employee Relationship Management; Business Organization; Well-being; Communications Industry; Telecommunications Industry; France

October 19, 2021
Article

The Facebook Trap

Facebook has a clear mission: Connect everyone in the world. Clarity is good, but in Facebook’s case, it has also put the company in a bind because the mission—and the company’s vision for creating value through network effects—has also become the source of its biggest... View Details

Keywords: Business And Society; Mission and Purpose; Network Effects; Value Creation; Corporate Accountability; Strategy

Register to Read

March 2021 (Revised December 2023)
Case

Capitalism and the Party-State: The People's Republic of China at 70

By: Meg Rithmire and Courtney Han

In 2019, the People’s Republic of China (PRC) turned seventy-years-old and became the longest active authoritarian regime in recent history. By then, China was the world’s second largest economy by GDP (after the United States), and a high-technology industrial... View Details

Keywords: Party-state; Economic Systems; Business and Government Relations; Economy; Society; International Relations; China

January 2021 (Revised June 2021)
Case

Hester Pharmaceuticals (A): A Pricing Dilemma

By: Dante Roscini and John Masko

In August 2019, the leadership of Hester Pharmaceuticals (Hester) had a problem. Italy promised to be a key market for their new breakthrough oncology drug Akrozumab, but for almost two years, its single-payer healthcare system had been unable to agree with Hester on a... View Details

Keywords: Macroeconomics; Trade; Price; Global Range; Global Strategy; Globalized Markets and Industries; Health Care and Treatment; Patents; Monopoly; Negotiation; Business and Government Relations; Risk and Uncertainty; Human Needs; Business Strategy; Commercialization; Pharmaceutical Industry; Italy

December 2020 (Revised June 2021)
Case

France Télécom (A): A Challenging Restructuring

By: Cynthia A. Montgomery and Ashley V. Whillans

These cases explore the impacts of industry shocks, resulting corporate actions that had a devastating impact on employees, and the legal conviction of corporate leaders for “institutional harassment."

This case series follows the evolution of France... View Details

September 2020
Teaching Note

TransDigm in 2017: The Beginning of the End or the End of the Beginning?

By: Benjamin C. Esty and Daniel Fisher

Teaching Note for HBS Case No. 720-422. TransDigm was a highly acquisitive company that manufactured a wide range of highly engineered aerospace parts for both military and commercial customers. Over the ten years ending in 2016, its stock price had increase ten times,... View Details

June 2020
Supplement

TransDigm in 2017: Congressional Hearing on the DoD Inspector General’s Report (5/15/19)

By: Benjamin C. Esty

This video accompanies the case, “TransDigm in 2017: The Beginning of the End or the End of the Beginning?” View Details

June 2020
Article

Informing Dissent

By: Hillary Greene and Dennis Yao

The first part of this commentary argues that because the production of dissent depends on the availability of information, greater attention should focus on government restrictions on access to official information. At no time is this more important than when... View Details

Keywords: Dissent; Information Monopoly; Economics Of Speech; Freedom Of Information Act (FOIA); Self-censorship; Social Pressure; Information; Government and Politics; Spoken Communication; Society

Find at Harvard

May 2020
Case

Trust Merchant Bank

By: Ramon Casadesus-Masanell, Pippa Tubman Armerding, Dilyana Karadzhova Botha and Salim Dewji

Trust Merchant Bank (TMB), a leading bank in the Democratic Republic of Congo (DRC), needs to decide whether to enter the soon-to-be-liberalized insurance industry. Since its founding in 2004, TMB has played a pivotal role in reshaping the DRC banking landscape by... View Details

Keywords: Retail Banking; Financial Services; Financial Inclusion; Turnaround; Fintech; Banks and Banking; Financial Condition; Insurance; Corporate Strategy; Expansion; Business Model; Family Business; Entrepreneurship; Information Technology; Monopoly; Banking Industry; Insurance Industry; Africa; Congo, Democratic Republic of the

April 2020 (Revised April 2023)
Case

TransDigm in 2017: The Beginning of the End or the End of the Beginning?

By: Benjamin C. Esty and Daniel Fisher

TransDigm was a highly acquisitive company that manufactured a wide range of highly engineered aerospace parts for both military and commercial customers. Over the ten years ending in 2016, its stock price had increased ten times, and both EBITDA and revenues had grown... View Details

January 2020 (Revised October 2023)
Case

Governing PG&E

By: Lynn S. Paine and Will Hurwitz

The five commissioners of the California Public Utilities Commission (CPUC) listened intently at a public forum in April 2019 as PG&E Corporation’s out-going chairman Richard Kelly described the company’s proposed new board. PG&E, which provided electricity and natural... View Details

January 2020
Case

The Origins of Bell Labs

By: Tom Nicholas and John Masko

In 1947, scientists at Bell Labs invented the transistor—a tiny signal amplifier that would go on to become the fundamental building block of the digital age. But, confounding most traditional economic assumptions, it was not a vigorous startup that made this momentous... View Details

Keywords: Business History; Innovation Leadership; Technological Innovation; Patents; Monopoly; Organizational Structure; Competitive Strategy; Telecommunications Industry; Boston; Massachusetts; New York (city, NY)

2019
Article

Pay-for-Monopoly?: An Assessment of Reverse Payment Deals by Pharmaceutical Companies

By: Sana Rafiq and Max Bazerman

Abstract Over the past eighteen years, pharmaceutical firms have developed a blueprint to impede competition in order to maintain their monopoly profits. This scheme, termed pay-for-delay, involves direct or indirect payment of money from a branded-drug manufacturer... View Details

Keywords: Monopoly; Policy; Competition; Agreements and Arrangements; Pharmaceutical Industry

2018
Chapter

The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century

By: Nicholas Bagley, Benjamin Berger, Amitabh Chandra, Craig Garthwaite and Ariel Dora Stern

On the 35th anniversary of the adoption of the Orphan Drug Act (ODA), we describe the enormous changes in the markets for therapies for rare diseases that have emerged over recent decades. The most prominent example is the fact that the profit-maximizing price of new... View Details

Keywords: Health Care and Treatment; Laws and Statutes; Research and Development; Investment; Markets; Monopoly

Find at Harvard

Register to Read

1
2
3
4
5
→